Chief Executive Officer
Isaac Bright is co-founder and CEO of RubrYc Therapeutics, leveraging more than 15 years of experience as a physician-entrepreneur to realize our vision and lead our operations. Before joining RubrYc, Isaac was both an operating executive and an accomplished investor in companies (startups through Fortune 500) throughout life science sectors. He launched RubrYc to create novel medicines for patients in need. Isaac earned his B.A. in Biochemistry from Pepperdine University, his MD from the Stanford University School of Medicine, and his MBA as a Howard E. Mitchell Fellow at The Wharton School.
Fun Fact: Isaac was the first in his family to graduate from college & “Finish a Marathon” is no longer on Isaac’s bucket list.
Chief Technology Officer
Matthew Greving is co-founder and Chief Technology Officer at RubrYc Therapeutics. Matt is driven by a passion to utilize the power of integrated computation and laboratory discovery to solve difficult problems in human health. He co-founded RubrYc to pursue this passion and act on his belief that we are at the very early stage of computation-laboratory integration in biological discovery. Growing up on a farm too far to visit friends, Matt developed a love for programming at age 12 with a Commodore 64 computer writing simple programs in his bedroom. He left the farm for undergraduate study in Computer Science and worked as a Software Engineer for 8 years. At that time, he pursued his passion for integrated biological-computational research and received a Ph.D. in Biochemistry. After receiving his Ph.D., he spent the last 16 years applying his biological and computational experience in drug discovery and diagnostics, primarily in early R&D environments of startups.
Fun Fact: Matt was a competitive skydiver before being introduced to alpine rock & ice climbing. He particularly loves climbing the mountains in the Alaska and Himalaya ranges.
Olga Monterrosa is the Executive Administrator at RubrYc Therapeutics. Olga brings 6 years of experience in business development and operations. Before joining RubrYc Therapeutics, Olga worked for a local startup franchise based business and was instrumental in helping them grow from 3 locations to 50 nation wide, within 3 years. Olga studied the English and Spanish Languages at State University in Ukraine and when she moved to the US, she furthered her education by completing a top tier Web Development Bootcamp.
Fun Fact: Olga was born and raised in Ukraine and moved to the US at a young age by herself. She enjoys reading, spending time with her family, and weekend trips to new places.
Senior Principal Scientist, Machine Learning
Alex Taguchi is RubrYc's Senior Principal Scientist, who is in charge of researching, building, and implementing artificial intelligence for antibody drug discovery. He has authored more than 20 peer-reviewed scientific publications in protein computational biology. Alex attained dual Physics (B.S.) and Japanese (B.A.) degrees from the University of California San Diego, and his Ph.D. in Biophysics from the University of Illinois Urbana-Champaign. He was a National Institutes of Health postdoctoral fellow at the Massachusetts Institute of Technology before joining the team at RubrYc Therapeutics.
Fun Fact: Alex can do a backflip with a high likelihood of not landing on his face.
Platform R&D Manager
Cody Moore is a Platform R&D Manager at RubrYc Therapeutics. After receiving a master’s in Biochemistry from Arizona State University, he focused on creating high-throughput assays and analytics for diagnostics applications at HealthTell. This focus has shifted towards drug discovery with the formation of RubrYc Therapeutics in 2018.
Fun Fact: Cody is a talented musician.
Gao is the Sr. Scientist in platform R&D group at RubrYc Therapeutics. He is a part of the team generating antibodies with special functions and unique epitopes through MEMs immunization and B cell libraries. Gao brings more than 20 years of experience in antibody discovery and development from Research Institute and biotech companies including NIH, Protein Design Labs, Astellas, 23andMe and Denali Therapeutics.
Fun fact: Gao enjoys outdoor activities.
Alina is an Associate Scientist at RubrYc Therapeutics. She earned her B.S. in Bioengineering from UC Riverside. Alina brings an engineering and molecular biology hybrid skillset to our team. After graduation Alina worked at Illumina where she helped develop the next iteration of flowcells for NGS devices. Before joining the team at Rubryc Alina worked at Fluidigm where she focused on assay development and optimization for pathogen panels including the novel SARS-COV2 virus.
Fun fact: Alina was born in Cuba and moved to the US at a young age. She enjoys outdoor activities with her Rottweiler Kylo and playing League of Legends with friends.
Wiktoria is an Associate Scientist at RubrYc Therapeutics. She is an EU native from Poland, who grew in Brooklyn, New York. She started her academic career studying biochemistry & neuroscience at Smith College as a Posse Scholar. Mastering zebrafish model systems to study Autism, she went on to expand her developmental biology skills studying dementia at Gladstone Institutes studying the role of tau protein, before joining RubrYc Therapeutics for discovery research.
Fun fact: Name is spelled in the Polish alphabet! She occasionally reads Latin poems. 5th grade artwork was showcased briefly at the Guggenheim Museum.
Mohan Srinivasan, Ph.D., was the Co-Founder and VP, Discovery R&D for RubrYc’s first year operating.